European Patent Office

T 2137/13 of 04.10.2017

European Case Law Identifier
ECLI:EP:BA:2017:T213713.20171004
Date of decision
4 October 2017
Case number
T 2137/13
Online on
10 October 2017
Petition for review of
-
Application number
03738060.7
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Salmeterol superfine formulation
Applicant name
CHIESI FARMACEUTICI S.p.A.
Opponent name
NORTON HEALTHCARE LIMITED
Board
3.3.07
Headnote
-
Keywords
Lapse of patent in all designated states - termination of appeal proceedings
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal proceedings are terminated.